New Year Picks 2018
New Year Picks 2018
New Year Picks 2018
05-01-2018
New Year Picks - 2018
05-01-2018
India, gearing up for a new dawn - a prolonged
phase of mild goldilock scenario
2017 has drawn to an end with ~28% gain for Nifty – BEST since 2013 – and a closing lifetime high for the benchmarks. However the rally would at best be termed as a „reluctant rally‟ as many
investors have been wary of participation owing to valuation concerns.
Given this backdrop, a common Q that investors are pondering upon is, “whether a significant correction is in sight”.
ABM Take :
GLOBAL FINANCIAL & ECONOMIC CONDITIONS:
Record equity index levels are not good enough reasons to be on the sidelines. Outlook for the riskier assets remains constructive and we maintain risk-on stance going into 2018. Global synchronized
economic growth (seen for the first time in many years), steady earnings growth, decent liquidity (as global central banks adopt „go slow” approach in withdrawing record monetary stimulus), continues
to support risk-on assets. The Goldilocks witnessed in 2017, (characterised by stronger than expected demand across China and G3, little inflation, and ever rising asset markets), will be a hard act to
follow – The tide may rise slowly in 2018 as compared to 2017. China‟s 5Y plan – focused on level and quality of growth should act as an anchor of economic growth and investment confidence in the
region. This coincides with Japanese growth supported by Abenomics and gradual return of growth momentum in India. Sentiment towards GEM more broadly should also lead to increased fund
allocation towards EMs. While the returns are likely to moderate (as compared to 2017) risks too have come off somewhat as 2018 take off, with geo-political tensions between NK and US somewhat
receding. However, it remains a key monitorable.
DOMESTIC FINANCIAL & ECONOMIC CONDITIONS:
India is entering into a prolonged phase of Mild Goldilock scenario with the return of growth momentum amidst stable interest rates and only moderate inflation.
Cyclical forces (twin balance-sheet stress and weak external trade) and structural changes (expedited formalisation) have hurt India‟s growth over the past few quarters. Real GDP growth has slowed
from 7.9% in Q1FY17 to a multi-year low of 5.7% in Q1 FY18. With businesses still adjusting to the GST adoption, slow progress in corporate deleveraging, and slightly reduced room for fiscal support,
we expect FY18 GDP growth @ 6.6% in FY18 as compared to 7.1% in FY17. However H2FY18 growth is estimated @ 7.2% vs 6.0% for H1FY18. We expect the economy to recover to 7.3% YoY in
FY19. Consumption is expected to drive this revival through moderation in GST rates and trade channels normalising. Lead indicators, including auto sales and personal credit growth (for urban
spending), as well as non-durables output (rural demand) are fast improving.
The private capex cycle is expected to recover (One of India‟s largest steel company recently announced a big ticket ~25k crore, 5MT capacity expansion) from the trough due to deleveraging efforts,
institutional reforms, benign interest rates and increasing capacity utilization in select industries. Government expenditure is likely to rise on account of 2018 being a pre-election year, albeit focused
on fixing supply gaps rural stress and infrastructure bottlenecks rather than boosting low quality demand through subsidies, handouts etc. Hence, we expect the govt to resist giving in to outright
populism and remain on the path of fiscal consolidation, even if the glide path is more gradual than anticipated earlier.
The recent rating upgrade from Moody‟s was a big boost to sentiment and is likely to lower offshore borrowing costs for large Indian companies. It would also support robust inflow of FDI, FPI flows as
we progress through 2018.
3
India, gearing up for a new dawn - a prolonged
phase of mild goldilock scenario
4
Piramal Enterprises Ltd CMP ` 2854
Pharma Business: PEL is the third-largest player (with ~12% market share) in the global inhalation anesthesia space. The P/E (x) 39.3 31.5 21.8
company ranks among the top-7 players in the OTC space (ranked 40th in 2007). PEL has expanded its distribution reach Source: Bloomberg Consensus, ABML Research
to 1,500 towns (~480 towns in FY15), with a field force of ~2,000 (~800 in FY15). We expect margins in this business to
expand (achieved breakeven in FY16) on positive operating leverage and sales force automation. The company has
invested ~Rs 30bn in the past two years to acquire seven assets. We expect PEL to achieve pharma revenue and EBITDA
CAGR of ~16-18% and 30-35% over FY17-20, largely driven by recent acquisitions, ADC manufacturing capacity,
debottlenecking at other facilities and expansion into new areas.
Information Management Business: PEL‟s information management business originated from the acquisition of Decision
Resources Group, a decision-support platform in the healthcare information services space. It intends to scale up via
product innovation and geographical expansion, with active thrust on the inorganic route.
5
RBL Bank Limited CMP ` 540
keep its CoF under check. NIM has improved from 3.4% in Q2FY17 to 3.7% in Q2FY18. We expect NIM improvement Source: Bloomberg Consensus, ABML Research
trajectory to continue going ahead.
Operating leverage to kick in: RBL has made significant investment in past few years with respect to human capital,
technology, service offering, customer acquisition, brand building, etc. We expect all these investments to fructify which
shall led to lower cost to income ratio going ahead, thereby supporting profitability.
Valuation: We believe RBL to continue to command premium valuation on account of superior credit growth and strong
earnings growth as operating leverage kicks in. Also, strong management pedigree provides comfort to us. Return ratios
are set to improve from 1.2% now to 1.5% by FY20 owing to i) NIM improvement, ii) rising share of fee income and iii)
expected fall in C/I ratio. Profit is expected to grow by ~40% CAGR over FY17-20E.
6
Balaji Amines Limited CMP ` 660
expected to get massive cost advantage under this project on account lower power costs, tax rebates and other benefits. Source: Bloomberg Consensus, ABML Research
Hotel business has also started showing cash profit. The current occupancy rate is at 70%. As on September 2017, debt
on the books was at Rs 27 crore. As per management, it shall reduce to Rs 15 crore by March 2018. Balaji has
consistently worked on efficiency and cost reduction measures in the past 24-30 months. As a result, it has the lowest
fixed costs ratio among its peers.
We expect revenues of ~1050 crore by FY19 as against 670 crore in FY17, and PAT should grow at a CAGR of 27-30%
over FY17-FY19. At CMP, the stock is trading at 16x of FY19 earnings.
7
PSP Projects Limited CMP ` 547
Residential and Government Residential (Institutional + Industrial which accounts for 80%+). PAT 0.4 0.5 0.8
Strong Execution track record make it qualified to bag large products in future too: PSP Projects has a successful track ROE (%) 47.5 27.0 32.2
record of delivering quality building services & completing the projects before time due to active involvement of
P/E (x) 47.0 34.5 23.5
management in execution of projects & their thorough understanding of the business. It was selected as a preferred
construction company for GIFT City, Gandhinagar. Its other marquee projects/clients include Sabarmati Riverfront Source: Bloomberg Consensus, ABML Research
Development Corp, Cadila Healthcare, Zydus Hospital, Amul Dairy etc. Because of its exceptional execution capability, it
recently bagged marquee project of Surat Diamond Bourse of Rs.1575cr, its largest contract so far. Its total order book
stands at Rs.~2700cr in Dec 2017 & ~Rs300cr orders in pipeline.
Financials and Valuation: PSP Projects‟ revenue has grown at a CAGR of 21% over FY12-FY17, while its Operating profit
and PAT has grown at a CAGR of 34% and 38% over the same period. It operates under Asset Light Model and enjoys a
Debt Free status. This has led to high ROE of 43%+ over past five years. Company is currently valued at 35x and 24x
FY18E and FY19E PE. Huge order books provide revenue visibility for next 3yrs and looking at the prospects of the
company, it is well poised to bag orders in future too. We expect the stock to deliver 30% returns over 12M.
8
Century Plyboards (I) Ltd CMP ` 344
channel where there are established Brands which will be available at relatively competitive prices. Players like Century Source: Bloomberg Consensus, ABML Research
Plyboards are well placed to encash on such drive and emerge as one of the bigger beneficiary.
Push for Housing For All: With government‟s goal of constructing 10mn houses every year for pushing affordable housing,
there will be increased demand for building products like plywood. Century Plyboards has at the right time augmented its
capacity which included expanding plyboard capacity by 12%, laminate capacity by 50% and adding new 1,98,000 CBM
MDF capacity. This makes it ready to contend larger share in the incremental demand from housing segment.
Valuation wise, Century Plyboards is trading at 42x & 29x FY18E & FY19E PE. Considering the prospects of the industry
and the leadership position of Century Plyboard, it is well poised to en-cash on the large opportunity in organized space.
We expect the stock to deliver 25-30% returns over 12M.
. 9
The Phoenix Mills Ltd CMP ` 575
policies: India‟s retail industry grew by 11% in FY2017 and is expected to grow by 14-15% for next five years (as per PAT 1.7 2.5 3.3
crisilresearch). Increase in overall retail consumption along with shift towards organized retail has created huge demand
ROE (%) 8.3 11.8 13.0
for quality space in the retail industry. Phoenix is quality player in the space.
P/E (x) 51.9 35.3 26.7
Huge demand for quality Branded Retail Space: Top Global Brands Queue-up; PML commands decent premium: During the
first six months of 2017, India has topped the Global Retail Development Index overtaking China. PML has emerged as Source: Bloomberg Consensus, ABML Research
India‟s one of the most premium mall owner and manager. This helps it to command multi-fold premium from the high
end brands and shortage of quality space only adds to its position.
Outlook & Valuation: We believe PML is one of the best proxy to participate in the growing retail consumption in India,
benign interest rates & increasing disposable income. PML‟s steady revenue coupled with improving margins has led to
multifold profit growth for past three years. Its Net D/E is at 1.5x which should gradually come down as company intends
to maintain its current absolute debt. Its rental business has grown at a CAGR of 16% over FY13-17. It is currently valued
at 13x and 11.5x FY18E & FY19E EV/EBITDA and at 3.5x FY18E P/B. Given its strong position in the industry & proven
capabilities and interest rates trending lower, we believe PML should deliver 30% returns over 12M.
10
Research Team
Vivek Mahajan Hemant Thukral
Head of Research Head – Derivatives Desk
022-6225 7220 022-6225 7230
vivek.mahajan@adityabirlacapital.com hemant.thukral@adityabirlacapital.com
Fundamental Team
Avinash Nahata Head Equity Analyst 022-6225 7208 avinash.nahata@adityabirlacapital.com
Jaymin Trivedi Banking & Finance 022-6225 7275 jaymin.trivedi@adityabirlacapital.com
Naveen Baid IT 022-6225 7274 naveen.baid@adityabirlacapital.com
Suresh Gardas Pharma & Chemicals 022-6225 7271 suresh.gardas@adityabirlacapital.com
Mahavir Jain Mid - Cap 022-6225 7270 mahavir.jain@adityabirlacapital.com
Mohan Jaiswal Technical Analyst 022-6225 7273 mohan.jaiswal@adityabirlacapital.com
Salim Hajiani Equity Advisor 022-6225 7277 salim.hajiani@adityabirlacapital.com
Pradeep Parkar Equity Advisor 022-6225 7272 pradeep.parkar@adityabirlacapital.com
Quantitative Team
Sudeep Shah Sr.Technical Analyst 022-6225 7265 sudeep.shah@adityabirlacapital.com
Rahil Vora Technical Analyst 022-6225 7266 rahil.vora@adityabirlacapital.com
Smita Dhale Sr.Executive –Derivative Desk 022-6225 7269 smita.dhale@adityabirlacapital.com
ABML research is also accessible in Bloomberg at ABMR
Disclaimer:
Aditya Birla Money Limited (ABML) is in the business of offering investments & trading in Stock and Securities through its various affiliations with Stock Exchanges. It offers Portfolio Management Services to HNI and Corporate
investors. ABM also caters to investments in Debt instruments and Mutual funds through it digital platform to diversify asset allocation. As a depository participant, ABM has equity assets under custody worth around Rs. 25,000
crores catering to over 3 lac investors who can hold Stocks & Securities, Mutual funds and Insurance policies in electronic form.
This document is not for public distribution and is meant solely for the personal information of the authorized recipient. No part of the information must be altered, transmitted, copied, distributed or reproduced in any form to any
other person. Persons into whose possession this document may come are required to observe these restrictions. This document is for general information purposes only and does not constitute an investment advice or an offer to
sell or solicitation of an offer to buy / sell any security and is not intended for distribution in countries where distribution of such material is subject to any licensing, registration or other legal requirements.
The information , opinion, views contained in this document are as per prevailing conditions and are of the date of appearing on this material only and are subject to change. No reliance may be placed for any purpose whatsoever
on the information contained in this document or on its completeness. Neither ABML, its group companies, its directors, associates, employees nor any person connected with it accepts any liability or loss arising from the use of
this document. The views and opinions expressed herein by the author in the document are his own and do not reflect the views of Aditya Birla Money Limited or any of its associate or group companies. The information set out
herein may be subject to updating, completion, revision, verification and amendment and such information may change materially. Past performance is no guarantee and does not indicate or guide to future performance.
Nothing in this document is intended to constitute legal, tax or investment advice, or an opinion regarding the appropriateness of any investment, or a solicitation of any type. The contents in this document are intended for general
information purposes only. This document or information mentioned therefore should not form the basis of and should not be relied upon in connection with making any investment. The investment may not be suited to all the
categories of investors. The recipients should therefore obtain your own professional, legal, tax and financial advice and assessment of their risk profile and financial condition before considering any decision.
ABML, its associate and group companies, its directors, associates, employees from time to time may have various interests/ positions in any of the securities of the Company (ies) mentioned therein or be engaged in any other
transactions involving such securities or otherwise in other securities of the companies / organization mentioned in the document or may have other interest with respect of any recommendation and / related information and
opinions.
In the last 12 months period ending on the last day of the month immediately preceding the date of publication of this research report, ABML or any of its associates may have managed or co-managed public offering of securities
from subject company of this research report, or received compensation for investment banking or merchant banking or brokerage services from subject company of this research report, or received compensation for products or
services other than investment banking or merchant banking or brokerage services as applicable from the subject company of this research report or the Subject Company may have been a client of ABML or its associates during
twelve months preceding the date of distribution of the research report. ABML and it's associates have not received any compensation or other benefits from the subject company or third party in connection with the research
report. The company follows employee trading policy which regulates the trading activities of the research analyst. The company policy do not restricts the compensation of research analyst linked with the recommendations
provided therein.
Aditya Birla Money Limited is registered as a Research Analyst under SEBI (Research Analyst)
Regulations, 2014. SEBI Reg. No. INH000002145
Thanks